PE16899A1 - Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las que estan presentes - Google Patents

Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las que estan presentes

Info

Publication number
PE16899A1
PE16899A1 PE1997001013A PE00101397A PE16899A1 PE 16899 A1 PE16899 A1 PE 16899A1 PE 1997001013 A PE1997001013 A PE 1997001013A PE 00101397 A PE00101397 A PE 00101397A PE 16899 A1 PE16899 A1 PE 16899A1
Authority
PE
Peru
Prior art keywords
lis
amino acid
treatment
combination
alkyl
Prior art date
Application number
PE1997001013A
Other languages
English (en)
Inventor
Jacques Paris
Remi Delansorne
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of PE16899A1 publication Critical patent/PE16899A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

SE REFIEREN A PEPTIDOS DE FORMULA V-W-X-SPL-Y-Pro-Z, EN DONDE: "V" ES A1A2, DONDE: A1 ES ACIDO PIROGLUTAMICO, ACETILSARCOSINA o D-AMINOACIDO AROMATICO; A2 ES UN ENLACE DIRECTO, His, DFen, DpFFen o DpClFen; "W" ES UN AMINOACIDO AROMATICO; "X" ES A3A4, DONDE: A3 ES Ala, Thr, Ser, DSer, Ser(OBzl) o N-METILSERINA; A4 ES Tir, Fen, CIS-3-(4-PIRAZINILCARBONILAMINOCICLOHEXIL)ALANINA, N-PICOLINOIL-Lis, N-NICOTIL-Lis, N-ISOPROPIL-Lis; SPL ES EL RADICAL DE FORMULA (i); "Y" ES A5A6, DONDE: A5 ES UN AMINOACIDO CON UNA CADENA LATERAL ALQUILO C1-C8 o CICLOALQUILO C3-C6; A6 ES Arg, HArg (OPCIONALMENTE SUSTITUIDOS POR ALQUILO C1-C4), Lis, HLis, Orn, p-AMINOFENILALANINA (OPCIONALMENTE SUSTITUIDOS POR ISOPROPIL, NICOTINOIL o PICOLINOIL), CITRULINA (Cit), HCit; "Z" ES GliNH2, DAlaNH2, AZAGliNH2 o NHR1, DONDE R1 ES ALQUILO C1-C4, CICLOALQUILO C3-C6 o HETEROCICLO. ESTOS PEPTIDOS ACTUAN COMO ANTAGONISTAS Y AGONISTAS DE LA HORMONA LUTEINIZANTE (LH-RH), SIENDO UTILES EN COMBINACION CON UN ESTEROIDE SEXUAL O UNA GONADOTROPINA EN EL TRATAMIENTO DE LA INFERTILIDAD, CONDICIONES HIPOGONADICAS, HIPERGONADICAS, O DE MANERA INVERSA COMO ANTICONCEPTIVO; EN COMBINACION CON UN INHIBIDOR DE ACCION ANDROGENICA, EN EL TRATAMIENTO DEL CANCER DE PROSTATA O DE LA HIPERTROFIA PROSTATICA BENIGNA O EN COMBINACION CON UN ANTIESTROGENO EN EL TRATAMIENTO DEL CANCER DE MAMA
PE1997001013A 1996-11-14 1997-11-12 Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las que estan presentes PE16899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96402441A EP0842946A1 (en) 1996-11-14 1996-11-14 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
PE16899A1 true PE16899A1 (es) 1999-02-19

Family

ID=8225315

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997001013A PE16899A1 (es) 1996-11-14 1997-11-12 Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las que estan presentes

Country Status (28)

Country Link
US (1) US6153587A (es)
EP (2) EP0842946A1 (es)
JP (1) JP2001503444A (es)
KR (1) KR20000068975A (es)
CN (1) CN1237979A (es)
AP (1) AP9901529A0 (es)
AT (1) ATE196914T1 (es)
AU (1) AU5481798A (es)
BR (1) BR9713060A (es)
CA (1) CA2270158A1 (es)
CO (1) CO4930283A1 (es)
CZ (1) CZ172899A3 (es)
DE (1) DE69703308D1 (es)
EE (1) EE9900174A (es)
HU (1) HUP0000249A3 (es)
ID (1) ID21990A (es)
IL (1) IL129821A0 (es)
JO (1) JO1999B1 (es)
MA (1) MA26447A1 (es)
NO (1) NO992298L (es)
NZ (1) NZ335454A (es)
OA (1) OA11045A (es)
PE (1) PE16899A1 (es)
PL (1) PL333358A1 (es)
TN (1) TNSN97173A1 (es)
TR (1) TR199901054T2 (es)
WO (1) WO1998021229A1 (es)
ZA (1) ZA9710254B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
WO2000064926A1 (fr) * 1999-04-26 2000-11-02 Ajinomoto Co., Inc. Inhibiteur hormonal stimulant les melanocytes
US8821943B2 (en) * 2006-09-12 2014-09-02 Board Of Regents Of The University Of Nebraska Methods and compositions for targeted delivery of therapeutic agents
JP2023546032A (ja) * 2020-10-08 2023-11-01 ディグニファイ セラピューティクス エルエルシー 排尿および排便を誘発するための組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2270158A1 (en) 1998-05-22
US6153587A (en) 2000-11-28
EP0937101B1 (en) 2000-10-11
MA26447A1 (fr) 2004-12-20
EP0842946A1 (en) 1998-05-20
CO4930283A1 (es) 2000-06-27
CZ172899A3 (cs) 1999-08-11
ID21990A (id) 1999-08-19
JP2001503444A (ja) 2001-03-13
WO1998021229A1 (en) 1998-05-22
AP9901529A0 (en) 1999-06-30
ZA9710254B (en) 1998-05-28
TR199901054T2 (xx) 1999-07-21
CN1237979A (zh) 1999-12-08
IL129821A0 (en) 2000-02-29
DE69703308D1 (de) 2000-11-16
TNSN97173A1 (fr) 2005-03-15
EP0937101A1 (en) 1999-08-25
ATE196914T1 (de) 2000-10-15
NO992298L (no) 1999-07-08
KR20000068975A (ko) 2000-11-25
NO992298D0 (no) 1999-05-12
AU5481798A (en) 1998-06-03
BR9713060A (pt) 2000-04-11
EE9900174A (et) 1999-12-15
HUP0000249A3 (en) 2000-11-28
NZ335454A (en) 2000-10-27
OA11045A (en) 2003-03-07
PL333358A1 (en) 1999-12-06
HUP0000249A2 (en) 2000-07-28
JO1999B1 (en) 1999-05-15

Similar Documents

Publication Publication Date Title
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
PE84999A1 (es) Analogos del peptido lh-rh y composiciones farmaceuticas que los contienen
PL327146A1 (en) Antagonists of the gonadotrophin liberating hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
KR970701730A (ko) GnRH 길항물질(GNRH ANTAGONISTS)
ES8604265A1 (es) Un metodo para preparar un peptido o una sal no toxica del mismo.
CY1108063T1 (el) Gnrh ανταγωνιστες τροποποιημενοι στις θεσεις 5 και 6
AU7117498A (en) Gnrh antagonists
PE16899A1 (es) Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las que estan presentes
ATE161727T1 (de) Zyklische gnrh-antagonisten
ES8800277A1 (es) Un metodo para preparar peptidos que inhiben la liberacion de gonadotropina por la glandula pituitaria en mamiferos
NZ241755A (en) Gonadotropin releasing hormone analogs and intermediates containing unnatural amino acids
ITMI932154A1 (it) Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
EP0038135B1 (en) Lrf antagonists
AR009422A1 (es) Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las cuales estan presentes
EP0687685A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES
MX9804120A (es) Nuevos antagonistas de la lh-rh con efectividad mejorada.
RU99112124A (ru) Конформационно-ограниченные аналоги лг-рг, их применение и содержащие их фармацевтические композиции
IT1256247B (it) Peptidi ciclici
HU189504B (en) Process for preparing decapeptide derivatives inhibiting the release of luteinizing hormone

Legal Events

Date Code Title Description
FD Application declared void or lapsed